Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Derwent London (DLN.L)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (p) Price Target (p) Rating
2022-02-1632494100Buy
2022-07-2928683700Buy
2022-10-2420282800Buy
2023-01-0624162750Buy
2023-03-2822023000Buy
2023-09-2919272900Buy
2024-02-2319462425Buy
2024-03-1520682415Buy
2024-05-3123282620Buy
2024-09-0623902700Buy
2025-01-1719502400Buy
2025-03-2118362490Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS AG London Branch acts as broker to this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.